Cancer Tissue Gallery Cadherin-17 / CDH17

Adrenal gland – CDH17 negative adrenocortical adenoma.

Breast – CDH17 negative invasive lobular breast cancer.

Colon – Colorectal adenocarcinoma with strong CDH17 immunostaining of all tumor cells (CDH17 immunohistochemistry).

Esophagus – Adenocarcinoma showing strong CDH17 immunostaining of tumor cells (CDH17 immunohistochemistry).

Esophagus – CDH17 negative squamous cell carcinoma.

Ileum – Neuroendocrine tumor with strong CDH17 immunostaining of all tumor cells (CDH17 immunohistochemistry).

Kidney – CDH17 negative clear cell carcinoma.

Lung – Adenocarcinoma with variable CDH17 staining of most tumor cells (CDH17 immunohistochemistry).

Lung – CDH17 negative adenocarcinoma.

Lung – CDH17 negative small cell carcinoma.

Lung – Neuroendocrine tumor depicting a strong CDH17 staining of tumor cells (CDH17 immunohistochemistry).

Lung- CDH17 negative neuroendocrine tumor.

Lymph node – CDH17 negative Hodgkin’s lymphoma.

Oral cavity – CDH17 negative squamous cell carcinoma.

Ovary – CDH17 negative serous high-grade carcinoma.

Ovary – Endometroid carcinoma with intense CDH17 immunostaining of tumor cells (CDH17 immunohistochemistry).

Ovary – Mucinous carcinoma with strong CDH17 immunostaining of tumor cells (CDH17 immunohistochemistry).

Pancreas – Adenocarcinoma of the papilla Vaterii with strong CDH17 staining of tumor cells (CDH17 immunohistochemistry).

Pancreas – CDH17 negative ductal adenocarcinoma.

Pancreas – CDH17 negative neuroendocrine tumor.

Pancreas – Neuroendocrine tumor with strong CDH17 staining ofa small fraction of tumor cells (CDH17 immunohistochemistry).

Prostate – Adenocarcinoma (Gleason 4+4=8) with strong CDH17 positivity in 30_ of tumor cells.

Prostate – CDH17 negative adenocarcinoma (Gleason 3+3=6).

Salivary gland – CDH17 negative Warthin tumor.

Soft tissue – CDH17 negative liposarcoma.

Stomach – CDH17 negative gastrointestinal stromal tumor (GIST).

Stomach – Gastric adenocarcinoma (diffuse type) with strong CDH17 staining of tumor cells (CDH17 immunohistochemistry)

Stomach – Gastric adenocarcinoma (intestinal type) exhibiting a strong CDH17 immunostaining of all tumor cells (CDH17 immunohistochemistry).

Testis – CDH17 negative seminoma.

Thyroid – CDH17 negative papillary carcinoma.

Urinary bladder – CDH17 negative muscle-invasive urothelial carcinoma.